A detailed history of Kingsview Wealth Management, LLC transactions in Zai Lab LTD stock. As of the latest transaction made, Kingsview Wealth Management, LLC holds 8,794 shares of ZLAB stock, worth $239,548. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,794
Previous 9,349 5.94%
Holding current value
$239,548
Previous $225,000 2.22%
% of portfolio
0.0%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025

SELL
$24.61 - $33.18 $13,658 - $18,414
-555 Reduced 5.94%
8,794 $230,000
Q3 2024

Nov 12, 2024

BUY
$16.25 - $24.14 $151,921 - $225,684
9,349 New
9,349 $225,000
Q4 2023

Feb 08, 2024

BUY
$22.97 - $30.58 $169,886 - $226,169
7,396 New
7,396 $202,000
Q2 2023

Aug 10, 2023

BUY
$25.3 - $39.67 $253 - $396
10 Added 0.14%
7,406 $205,000
Q1 2023

May 15, 2023

BUY
$30.21 - $48.1 $223,433 - $355,747
7,396 New
7,396 $245,000
Q3 2022

Nov 14, 2022

BUY
$34.2 - $51.69 $6,498 - $9,821
190 Added 2.81%
6,956 $238,000
Q2 2022

Aug 16, 2022

SELL
$23.14 - $49.68 $1,550 - $3,328
-67 Reduced 0.98%
6,766 $235,000
Q1 2022

Feb 08, 2024

SELL
$27.77 - $64.4 $19,966 - $46,303
-719 Reduced 9.72%
6,677 $293,000
Q4 2021

Feb 17, 2022

BUY
$54.9 - $105.21 $100,247 - $192,113
1,826 Added 36.47%
6,833 $429,000
Q3 2021

Dec 03, 2021

BUY
$105.0 - $178.37 $51,240 - $87,044
488 Added 10.8%
5,007 $528,000
Q2 2021

Aug 17, 2021

BUY
$125.11 - $180.0 $19,642 - $28,260
157 Added 3.6%
4,519 $806,000
Q1 2021

May 24, 2021

BUY
$126.27 - $191.71 $134,603 - $204,362
1,066 Added 32.34%
4,362 $571,000
Q4 2020

Feb 16, 2021

BUY
$81.94 - $135.34 $39,822 - $65,775
486 Added 17.3%
3,296 $446,000
Q3 2020

Nov 19, 2020

BUY
$73.3 - $89.48 $439 - $536
6 Added 0.21%
2,810 $234,000
Q2 2020

Aug 14, 2020

BUY
$48.82 - $82.53 $136,891 - $231,414
2,804 New
2,804 $230,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.67B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Kingsview Wealth Management, LLC Portfolio

Follow Kingsview Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.